This article explains what HPAPIs are, why they are increasingly important, and the safety and containment technologies required for compliant manufacturing.
This article provides a comprehensive overview of the pharmaceutical intermediates manufacturing process, covering core steps such as raw material sourcing, multi-step synthesis, purification, and quality control.
A concise overview of the top 10 oncology intermediates expected to drive cancer therapy innovation in 2025, including PROTAC, ADC linkers, PARP cores, and radiopharmaceutical chelators.
A randomized clinical trial found that a citrus-grape-hesperidin-chromium supplement improved fasting glucose in 3 months and significantly enhanced lipid profiles in prediabetic adults over 6 months.
Discover how Orforglipron and smart breakfast choices improve blood-sugar control, boost energy, and reduce diabetes risk. Learn science-backed strategies today.
Discover key data integrity challenges in pharmaceutical intermediates manufacturing and learn practical strategies to ensure compliance, reliability, and patient safety.
This guide shares real-world insights on auditing suppliers, detecting data integrity risks, and validating quality systems.
This article explores how advanced pharmaceutical intermediates empower CDMO partnerships by enhancing drug development speed, quality, and efficiency.
This article explores practical ways to reduce pharmaceutical intermediate costs through smarter supply chain management, optimized synthesis routes, process intensification, and green chemistry.
Tianming Pharmaceutical Group will participate in the 93rd China International Pharmaceutical Ingredients and Intermediates Exhibition (CPhI China 2025) from November 12–14 at the Chongqing International Expo Center, Booth N5M07.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.